Sort
64,565 grants matching “drug discovery”
Preclinical development of teixobactin, a new antibiotic
$996,881Dallas Hughes · Novobiotic Pharmaceuticals, Llc · R44 · FY2019 · AI
Novel Spectinamide Antibiotics for the Treatment of MDR/XDR Tuberculosis
$996,798Michelle M. Butler · Microbiotix, Inc · R44 · FY2021 · AI
Mu Opioid Receptor Modulator Development to Treat Opioid Use Disorder
$996,755Yan Zhang · Virginia Commonwealth University · UG3 · FY2019 · DA
A Continuous Manufacturing Platform for Complex Dosage Forms
$996,753Diane Jane Burgess · University Of Connecticut Storrs · U01 · FY2017 · FD
How do genome alterations cause human lung cancer?
$996,674Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2019 · CA
Targeting Epigenetic Circuits in B-Cell Lymphomas
$996,660Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R35 · FY2022 · CA
The PIP2-virus interface and PI 4-kinase: novel biology and validation targets
$996,649Jeffrey S Glenn · Stanford University · R01 · FY2016 · AI
The ExCITE Program: Expediting Commercialization, Innovation, Translation, & Entrepreneurship
$996,487Paula J Bates · University Of Louisville · U01 · FY2017 · HL
Inhibitors of Coronavirus Fidelity and Cap Methylation as Broadly Applicable
$996,397Mark R Denison · University Of Alabama At Birmingham · U19 · FY2014 · AI
Optimization of Protein Therapeutics Formulations
$996,395Lawrence J Delucas · Soluble Therapeutics, Inc. · R42 · FY2012 · GM
High-content behavioral phenotyping of model organisms in three dimensions with a gigapixel microscope
$996,377Mark Harfouche · Ramona Optics, Inc. · R44 · FY2025 · OD
Research and Development to Establish a Small Animal Model as a Significant Resource of High-Value Single-Domain Antibodies
$996,252Milen Kirilov · Ingenious Targeting Laboratory, Inc. · R44 · FY2024 · AI
Small Molecule Antagonists of PF4 for the Treatment and Prevention of HIT
$996,228Jay Edward Wrobel · Fox Chase Chemical Diversity Center, Inc · R44 · FY2020 · HL
Defining T cell epitopes in Dengue virus infection
$996,155Ramila Philip · Immunotope, Inc. · R44 · FY2012 · AI
Targeting leukocyte metabolism to treat human autoimmune disease
$996,128Jay L Rothstein · Immunext, Inc. · R44 · FY2019 · AI
Regulation of Hormone Receptors and Gonadal Genes
$995,914Maria Dufau Catt · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD
Safe and Efficacious Oral MIF Inhibitors for Rheumatoid Arthritis
$995,900Anderson Gaweco · Innovimmune Biotherapeutics Holding, Llc · R44 · FY2014 · AI
Safe and Efficacious Oral MIF Inhibitors for Rheumatoid Arthritis
$995,900Anderson Gaweco · Innovimmune Biotherapeutics Holding, Llc · R44 · FY2016 · AI
Safe and Efficacious Oral MIF Inhibitors for Rheumatoid Arthritis
$995,900Anderson Gaweco · Innovimmune Biotherapeutics Holding, Llc · R44 · FY2015 · AI
R-5280, A Novel Modified Superior Resistant Starch Therapy for Type 1 Diabetes
$995,869Christian Furlan Freguia · Rise Therapeutics, Llc · R44 · FY2024 · DK
Targeting leukocyte metabolism to treat human autoimmune disease
$995,802Jay L Rothstein · Immunext, Inc. · R44 · FY2020 · AI
Targeting leukocyte metabolism to treat human autoimmune disease
$995,802Jay L Rothstein · Immunext, Inc. · R44 · FY2018 · AI
NeuroExM
$995,608Jacob R Glaser · Microbrightfield, Llc · R42 · FY2023 · MH
Metabolic Discrimination of Unknown Bacterial Pathogens
$995,605John Peter Wikswo · Vanderbilt University · U01 · FY2006 · AI
Protozoan Population Genetics and Inflammation
$995,544Michael Grigg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI